Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

ACRO Biomedical Co., Ltd. (6748) Income Statement

ACRO Biomedical Co., Ltd. Income Statement

Last quarter (Q2 2026), ACRO Biomedical Co., Ltd.'s total revenue was NT$27.82M, an increase of 317.84% from the same quarter last year. In Q2, ACRO Biomedical Co., Ltd.'s net income was NT$-40.23M. See ACRO Biomedical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 38.26MNT$ 44.23MNT$ 51.06MNT$ 27.63MNT$ 21.83M
NT$ 12.17MNT$ 26.19MNT$ 39.12MNT$ 13.43MNT$ 14.54M
NT$ 104.38MNT$ 92.69MNT$ 87.78MNT$ 76.20MNT$ 68.10M
Depreciation and AmortizationNT$ 16.53MNT$ 13.48MNT$ 10.98MNT$ 9.21MNT$ 9.51M
NT$ -75.68MNT$ -48.31MNT$ -30.18MNT$ -51.57MNT$ -41.18M
NT$ -92.22MNT$ -66.50MNT$ -48.67MNT$ -62.77MNT$ -53.55M
NT$ 9.56MNT$ 2.58MNT$ 7.25MNT$ 1.89MNT$ 2.78M
NT$ -82.66MNT$ -62.07MNT$ -41.42MNT$ -60.88MNT$ -50.77M
NT$ -82.66MNT$ -62.09MNT$ -41.42MNT$ -60.88MNT$ -50.77M
Per Share Metrics
Basic EPSNT$ -1.35NT$ -1.01NT$ -0.79NT$ -1.29NT$ -1.43
Diluted EPSNT$ -1.35NT$ -1.01NT$ -0.79NT$ -1.29NT$ -1.43
Weighted Average Shares Outstanding61.23M61.22M52.43M47.38M35.51M
Weighted Average Shares Outstanding (Diluted)61.23M61.47M52.43M47.38M35.51M

Currency in TWD

ACRO Biomedical Co., Ltd. Earnings and Revenue History

-120M-60M060M-300 %-200 %-100 %0 %EarningsProfit Margin202020212022202320242025RevenueEarningsProfit Margin